dextrothyroxine has been researched along with Viremia in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Angkasekwinai, N; Avirutnan, P; Hunnangkul, S; Komoltri, C; Mairiang, D; Malasit, P; Niwattayakul, K; Prommool, T; Puttikhunt, C; Saleh-Arong, FA; Songjaeng, A; Suputtamongkol, Y; Tangthawornchaikul, N; Thammapalo, S; Yamasmith, E | 1 |
| Campbell, N; Denes, A; Fritz, J; Grant, C; Jacobson, S; Lairmore, M; Ratner, L; Suresh, R; Weil, G; Zimmerman, B | 1 |
| Baccard, M; Cordoliani, F; Feuilhade de Chauvin, M; Fournier, S; Morel, P; Tancrede, E; Vasseur, E | 1 |
1 trial(s) available for dextrothyroxine and Viremia
| Article | Year |
|---|---|
Ivermectin Accelerates Circulating Nonstructural Protein 1 (NS1) Clearance in Adult Dengue Patients: A Combined Phase 2/3 Randomized Double-blinded Placebo Controlled Trial.
Topics: Adult; Animals; Antiparasitic Agents; Dengue; Double-Blind Method; Humans; Ivermectin; Viral Nonstructural Proteins; Viremia | 2021 |
2 other study(ies) available for dextrothyroxine and Viremia
| Article | Year |
|---|---|
Effect of treatment of Strongyloides infection on HTLV-1 expression in a patient with adult T-cell leukemia.
Topics: Aged; Animals; Anthelmintics; Asian; DNA, Viral; Female; Human T-lymphotropic virus 1; Humans; Ivermectin; Japan; Leukemia-Lymphoma, Adult T-Cell; Mice; Mice, Inbred NOD; Mice, SCID; Neoplasm Transplantation; RNA, Viral; Specific Pathogen-Free Organisms; Strongyloides stercoralis; Strongyloidiasis; Viral Load; Viremia; Virus Replication | 2007 |
Ivermectin-responsive crusted scabies in HTLV1 carrier.
Topics: Aged; Aged, 80 and over; Antiparasitic Agents; Female; HTLV-I Infections; Humans; Immunocompromised Host; Ivermectin; Scabies; Scalp Dermatoses; Viremia | 1996 |